Company profile for Sientra

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Headquartered in Santa Barbara, California, Sientra is a medical aesthetics company exclusively focused on plastic surgery. The Company’s mission is to offer proprietary innovations and unparalleled partnerships that radically advance how plastic surgeons think, work and care for their patients. Sientra has developed a broad portfolio of products with technologically differentiated characteristics, supported by independent l...
Headquartered in Santa Barbara, California, Sientra is a medical aesthetics company exclusively focused on plastic surgery. The Company’s mission is to offer proprietary innovations and unparalleled partnerships that radically advance how plastic surgeons think, work and care for their patients. Sientra has developed a broad portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
420 South Fairview Avenue, Suite 200. Santa Barbara, California 93117
Telephone
Telephone
+1 805-562-3500
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

AMWC Asia-TDAC

AMWC Asia-TDAC

Not Confirmed

envelop Contact Supplier

AMWC Asia-TDAC

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2024/04/02/2856534/33599/en/Sientra-Announces-Completion-and-Winning-Bidders-of-its-Section-363-Sales-Auction.html

GLOBENEWSWIRE
02 Apr 2024

https://www.globenewswire.com//news-release/2024/02/13/2828253/33599/en/Sientra-to-Pursue-Strategic-Sale-of-its-Business-Through-Voluntary-Chapter-11-Process.html

GLOBENEWSWIRE
13 Feb 2024

https://www.globenewswire.com//news-release/2023/11/09/2777817/33599/en/Sientra-Reports-Third-Quarter-Financial-and-Operational-Results.html

GLOBENEWSWIRE
09 Nov 2023

https://www.globenewswire.com//news-release/2023/11/08/2776277/33599/en/Sientra-to-Present-at-the-Stifel-2023-Healthcare-Conference.html

GLOBENEWSWIRE
08 Nov 2023

https://www.globenewswire.com//news-release/2023/10/30/2769738/33599/en/Sientra-Reports-Preliminary-Unaudited-Third-Quarter-2023-Financial-Results-and-Provides-Update-on-Outlook.html

GLOBENEWSWIRE
30 Oct 2023

https://www.globenewswire.com/news-release/2023/08/10/2723122/33599/en/Sientra-Reports-Record-Second-Quarter-Financial-and-Operational-Results.html

GLOBENEWSWIRE
10 Aug 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty